Welcome back to part two of our series on primary HPV testing in cervical cancer screening. In this blog, we will focus on the various FDA-approved Human Papillomavirus (HPV) assays available in the U.S. Human Papillomavirus and Cervical Cancer HPV...
Laboratory Watch with
Dr. Chhieng
Laboratory
Watch with
Dr. Chhieng
Laboratory Watch–a new COLA blog for clinical laboratory professionals. It is intended to be an informative resource dedicated to helping pathologists, laboratory directors and clinical laboratory professionals perform their jobs better. Laboratory Watch will keep you and other laboratory professionals up-to-date on significant advancements in the field of laboratory science, the latest regulatory news and the opinions of experts in their field.
![Chief Medical Officer](https://www.cola.org/wp-content/uploads/2022/11/COLA_HS-1-scaled.jpg)
Chief Medical Officer
David Chhieng
MD, MBA, MSHI, MSEM, MLS, MDR
Since 2021
Dr. David Chhieng is the Chief Medical Officer of COLA. Before he joined COLA, he was a Professor, the Director of Anatomic Pathology and Pathology Informatics, and Vice Chair of Clinical Operation, of the Department of Pathology at the University of Washington in Seattle WA. Prior to that, he was the Director of Cytopathology at the Yale University and the Icahn School of Medicine at Mount Sinai.
Dr. Chhieng obtained his MD degree from the University of Hong Kong and completed several master degrees in Business Administration, Health Informatics Management, Engineering Management, Legal Studies and Dispute Resolution. His fellowship training in Surgical Pathology and Cytopathology at the Memorial Sloan Kettering Cancer Center and New York University, respectively. He is board certified in Anatomic and Clinical Pathology, Cytopathology, and Clinical Informatics. He has been a practicing surgical and cytopathologist for 20+ years and in a directorship position for 10+ years.
He has published 170+ peer-reviewed articles on the topics of cytopathology and surgical pathology. He has also co-authored several books and a number of book chapters. He has presented in many regional, national, and international pathology meetings and conferences. Dr. Chhieng has also served on a number of professional societies, including the ASCP Board of Directors; ASCP BOC Board of Governor. In addition, Dr. Chhieng has also served on the cytology test development and advisory committee of the American Board of Pathology, state commissioners for CAP Laboratory Accreditation Program, the Executive Board of ASC, and the work groups of the Bethesda System for Reporting Gynecology Cytology.
Primary HPV Testing in Cervical Cancer Screening (Part 1)
Greetings and welcome to the Laboratory Watch Blog! Today marks the commencement of our series focusing on Primary Human Papillomavirus (HPV) Testing in the context of cervical cancer screening. As a cytopathologist, I regard this paradigm shift as especially...
Understanding Viral Hemorrhagic Fevers: A Brief Overview
The Complex World of Viral Hemorrhagic Fevers Viral hemorrhagic fevers (VHFs) represent a diverse spectrum of diseases impacting both animals and humans. VHFs are caused by five distinct families of RNA viruses: Filoviridae, Flaviviridae, Rhabdoviridae,...
Overseeing Gain of Function Research in the U.S.: New Insights in the Wake of COVID-19 Revelations (Part 5)
Welcome to the final part of our series on Gain of Function Research (GOFR). This chapter highlights the National Science Advisory Board for Biosecurity’s (NSABB) newest recommendations, which seek to mitigate biosecurity and biosafety risks while advancing...
Demystifying the US Oversight Framework of Gain of Function Research (Part 4)
Welcome back to the fourth installment of our series focusing on Gain of Function Research (GOFR). In this entry, we turn our spotlight onto the current oversight frameworks in the United States designed to mitigate the biosecurity and biosafety risks inherent in...
Striking a Balance: Navigating the Risks and Rewards of Gain of Function Research (Part 3)
Welcome back to our ongoing series exploring Gain of Function Research (GOFR). In this third installment, we venture onto the tightrope of balancing the inherent risks and benefits of GOFR, while acknowledging the challenges along the way. Piecing Together the...
Unraveling the Risks and Benefits of Gain of Function Research (Part 2)
Welcome to the second chapter of our series exploring the complex world of Gain of Function Research (GOFR). In this post, we will shed light on the valuable benefits GOFR brings to the scientific table and explore the potential risks inherent in this innovative...
Diving into the Intricacies of Gain of Function Research (Part 1)
Welcome to the first installment of our illuminating 5-part series on Gain of Function Research (GOFR). Throughout this series, we will demystify the intriguing world of GOFR, covering its definitions, origin, applications and potential risks and benefits....
Burnout in the Laboratory: Part 4
Welcome to the last part of our 4-part discussion on burnout. In this blog, we will focus on the impact of digital pathology on pathologist burnout. Digital pathology, also known as whole slide imaging (WSI), consists of the digitalization of microscopic glass...
Stay Informed!
Stay informed about the latest regulatory announcements, upcoming events, trending accreditation news and other laboratory topics.